ORMP
Price
$2.58
Change
+$0.16 (+6.61%)
Updated
Nov 21 closing price
Capitalization
102.89M
95 days until earnings call
Intraday BUY SELL Signals
PMVP
Price
$1.32
Change
+$0.01 (+0.76%)
Updated
Nov 21 closing price
Capitalization
70.24M
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ORMP vs PMVP

Header iconORMP vs PMVP Comparison
Open Charts ORMP vs PMVPBanner chart's image
Oramed Pharmaceuticals
Price$2.58
Change+$0.16 (+6.61%)
Volume$763.46K
Capitalization102.89M
PMV Pharmaceuticals
Price$1.32
Change+$0.01 (+0.76%)
Volume$167.46K
Capitalization70.24M
ORMP vs PMVP Comparison Chart in %
ORMP
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ORMP vs. PMVP commentary
Nov 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and PMVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 22, 2025
Stock price -- (ORMP: $2.59 vs. PMVP: $1.32)
Brand notoriety: ORMP and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 459% vs. PMVP: 28%
Market capitalization -- ORMP: $102.89M vs. PMVP: $70.24M
ORMP [@Biotechnology] is valued at $102.89M. PMVP’s [@Biotechnology] market capitalization is $70.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 6 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 6 bullish, 3 bearish.
  • PMVP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than PMVP.

Price Growth

ORMP (@Biotechnology) experienced а +10.94% price change this week, while PMVP (@Biotechnology) price change was -4.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

ORMP is expected to report earnings on Feb 25, 2026.

PMVP is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($103M) has a higher market cap than PMVP($70.2M). ORMP YTD gains are higher at: 6.818 vs. PMVP (-12.583). ORMP has higher annual earnings (EBITDA): -22.07M vs. PMVP (-91.02M). PMVP has more cash in the bank: 142M vs. ORMP (97.9M). ORMP has less debt than PMVP: ORMP (912K) vs PMVP (1.02M). ORMP has higher revenues than PMVP: ORMP (2M) vs PMVP (0).
ORMPPMVPORMP / PMVP
Capitalization103M70.2M147%
EBITDA-22.07M-91.02M24%
Gain YTD6.818-12.583-54%
P/E Ratio2.58N/A-
Revenue2M0-
Total Cash97.9M142M69%
Total Debt912K1.02M89%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPPMVP
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signal:
Gain/Loss:
PMVP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUMSY1.760.05
+2.98%
Puma SE
PVCT0.07N/A
+1.98%
Provectus Biopharmaceuticals, Inc.
DLPX0.02N/A
N/A
Delphax Technologies, Inc.
ASEKF10.08N/A
N/A
Aisin Corporation
NNXPF1.64-0.02
-1.33%
Nanoxplore Inc.

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+0.76%
CLLS - PMVP
39%
Loosely correlated
-1.88%
SYRE - PMVP
35%
Loosely correlated
+3.37%
MTVA - PMVP
35%
Loosely correlated
+5.94%
CMVLF - PMVP
34%
Loosely correlated
N/A
RGNX - PMVP
33%
Loosely correlated
+8.60%
More